PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
PDF - Litblogs.net
PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
SI_2011_04 by Schweizer Illustrierte - Issuu
PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
Calaméo - GOUT.CH 2020 DE
PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - -
PEOPLE - HERZOG & DE MEURON
Bödeli Info April by WEBER VERLAG - Issuu
Erinnerungen 1848-1914 ..
Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - -
PEOPLE - HERZOG & DE MEURON
Migros-Magazin-20-2021-d-OS by Migros-Genossenschafts-Bund - Issuu
PDF) Abstracts of the 113th Annual Meeting of the Swiss Neurological Society, Congress Centre Kursaal Interlaken, Interlaken, Switzerland, 18–19 November 2021
HANSEstyle 4 | 2018
AAP Volltextsuche
europäisches medienkunst festival european media art ... - EMAF
(PDF) Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease
Gesamtkatalog_Winkler_Blätterkatalog
PDF) Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro
